{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:15:19Z","timestamp":1794651319462,"version":"4.9.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2020,8,14]],"date-time":"2020-08-14T00:00:00Z","timestamp":1597363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Amantadine is currently recommended for use in patients of posttraumatic brain injury with unconsciousness. However, the application of amantadine in consciousness disturbance after cerebral hemorrhage has only been rarely reported. This allows for a further exploration of the role of amantadine in the treatment of PVS resulting from severe cerebral hemorrhage.<\/jats:p>\n            <jats:p>Retrospective cohort study from 1\/2015 to 7\/2019 in Beijing Chaoyang hospital. We included adult patients treated with amantadine after severe cerebral hemorrhage in PVS. Primary outcome was time of consciousness recovery and Glasgow Out Scale scores after 5 months from onset. We compared characteristics and outcomes to a control cohort. matched on age, Coma Recovery Scale-Revised score, volume and location of hemorrhage.<\/jats:p>\n            <jats:p>Among the 12 patients who received amantadine treatment, 6 patients regained consciousness (50%) after 5 months of disease onset, but were still severely disabled. Besides, the time for regaining consciousness was within 3 months of disease onset. The remaining 6 patients were still in a PVS. Compared with the amantadine group, the consciousness recovery rate (50% vs 33.3%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.68) after 5 months in the nested control group was not significantly different. The awakening time for patients in the amantadine group was earlier than the control group (100% vs 25%, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a.03).<\/jats:p>\n            <jats:p>In this study, amantadine can accelerate the recovery of consciousness in patients following severe cerebral hemorrhage. We recommend further randomized controlled studies to determine the efficacy of amantadine.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000021822","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:14:15Z","timestamp":1597299255000},"page":"e21822","source":"Crossref","is-referenced-by-count":23,"title":["Persistent vegetative state after severe cerebral hemorrhage treated with amantadine"],"prefix":"10.1097","volume":"99","author":[{"given":"Yu","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,8,14]]},"reference":[{"key":"R1-20230915","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","article-title":"Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review","volume":"8","author":"Feigin","year":"2009","journal-title":"Lancet Neurol"},{"key":"R2-20230915","article-title":"Long-term survival and function after stroke","author":"Sennf\u00e4lt","year":"2018","journal-title":"Stroke"},{"key":"R3-20230915","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJM199405263302107","article-title":"The Multi-Society Task Force on PVS. Medical aspects of the persistent vegetative state","volume":"330","year":"1994","journal-title":"N Engl J Med"},{"key":"R4-20230915","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3109\/02699052.2011.556103","article-title":"Pharmacological and electrical stimulation in chronic disorders of consciousness: new insights and future directions","volume":"25","author":"Oliveira","year":"2011","journal-title":"Brain Inj"},{"key":"R5-20230915","first-page":"4121","article-title":"Pharmacological modulation of the state of awareness in patients with disorders of consciousness: an overview","volume":"20","author":"Mura","year":"2014","journal-title":"Curr Pharm Des"},{"key":"R6-20230915","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s40265-013-0138-8","article-title":"Pharmacotherapy for disorders of consciousness: are \u2019awakening\u2019 drugs really a possibility?","volume":"73","author":"Ciurleo","year":"2013","journal-title":"Drugs"},{"key":"R7-20230915","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/jnnp.2007.124099","article-title":"Measuring the effect of amantadine in chronic anoxic minimally conscious state","volume":"79","author":"Schnakers","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20230915","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/02699050400025059","article-title":"Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET)","volume":"19","author":"Kraus","year":"2005","journal-title":"Brain Inj"},{"key":"R9-20230915","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00001199-200208000-00004","article-title":"Amantadine to improve neurorecovery in traumatic brain injury associated diffuse axonal injury: a pilot double-blind randomized trial","volume":"17","author":"Meythaler","year":"2002","journal-title":"J Head Trauma Rehabil"},{"key":"R10-20230915","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1080\/026990599121061","article-title":"Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial doubleblind placebo-controlled study","volume":"13","author":"Schneider","year":"1999","journal-title":"Brain Inj"},{"key":"R11-20230915","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1102609","article-title":"Placebo-controlled trial of amantadine for severe traumatic brain injury","volume":"366","author":"Giacino","year":"2012","journal-title":"N Engl J Med"},{"key":"R12-20230915","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00701-014-2077-x","article-title":"Effect of amantadine in minimally conscious state of non-traumatic etiology","volume":"156","author":"Avecillas-Chas\u00edn","year":"2014","journal-title":"Acta Neurochir"},{"key":"R13-20230915","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1016\/j.apmr.2004.02.033","article-title":"The JFK Coma Recovery Scale-Revised: measurement characteristics and diagnostic utility","volume":"85","author":"Giacino","year":"2004","journal-title":"Arch Phys Med Rehabil"},{"key":"R14-20230915","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1212\/WNL.0000000000005926","article-title":"Practice guideline update recommendations summary: disorders of consciousness","volume":"91","author":"Giacino","year":"2018","journal-title":"Neurology"},{"key":"R15-20230915","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/0303-8467(92)90006-O","article-title":"Amantadine as N-methyl-D-aspartic acid receptor antagonist: new possibilities for therapeutic applications?","volume":"94","author":"Stoof","year":"1992","journal-title":"Clin Neurol Neurosurg"},{"key":"R16-20230915","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/026990598122386","article-title":"Amantadine: a potential treatment forthe minimally conscious state","volume":"12","author":"Zafonte","year":"1998","journal-title":"Brain Inj"},{"key":"R18-20230915","doi-asserted-by":"crossref","first-page":"709","DOI":"10.3109\/02699059409151025","article-title":"Clinical use of amantadine in brain injury rehabilitation","volume":"8","author":"Nickels","year":"1994","journal-title":"Brain Inj"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021822","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T01:16:22Z","timestamp":1694826982000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000021822"}},"subtitle":["A retrospective controlled study"],"short-title":[],"issued":{"date-parts":[[2020,8,14]]},"references-count":17,"journal-issue":{"issue":"33","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000021822","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,14]]}}}